导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.57% | 262/556 |
| 近一周 | 0.02% | 258/654 |
| 近一月 | - | 287/651 |
| 近一季 | 0.39% | 160/632 |
| 近半年 | 0.27% | 290/601 |
| 近一年 | 0.72% | 300/552 |
| 近两年 | 5.71% | 198/384 |
| 近三年 | 8.94% | 168/308 |
| 成立以来 | 16.73% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.44% 289/578 |
0.85% 262/615 |
-0.24% 332/651 |
- - |
| 2024 | 4.67% 201/561 |
1.21% 178/447 |
1.00% 261/495 |
0.43% 329/526 |
1.96% 211/561 |
| 2023 | 2.96% 152/408 |
0.53% 132/348 |
1.21% 164/358 |
0.45% 153/365 |
0.75% 191/408 |
| 2022 | 2.82% 63/341 |
0.59% 108/301 |
0.94% 57/320 |
1.02% 127/326 |
0.24% 95/341 |
| 2021 | 3.56% 153/309 |
0.53% 1306/2068 |
1.08% 973/2668 |
0.94% 1781/2731 |
0.96% 184/309 |
| 2020 | - - |
- - |
- - |
- - |
0.88% 1277/2563 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 鹏华中债1-3年农发行债券指数A VS. () |